Patent · US Active

Methods of using pegylated interleukin-10 for treating cancer

US9943568B2 · kind B2 · utility

1Cited by
49References
16Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 15, 2014
Grant dateApr 17, 2018
Priority date
Expiry dateApr 15, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treating subjects having a disease or disorder responsive to IL-10, including methods of administration and dosing regimens associated therewith, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.